护理学报 ›› 2019, Vol. 26 ›› Issue (20): 24-28.doi: 10.16460/j.issn1008-9969.2019.20.024
干眼症患者视力相关生活质量测评工具研究进展
安晓辉1, 孙福亮1, 曹淑卿2
- 1.天津中医药大学 研究生院,天津 301617;
2.天津市眼科医院 护理部,天津 300020
摘要： 目的 归纳总结干眼症患者视力相关生活质量测评工具,以供护士引进或自主研发相关测量工具提供参考依据。方法 对国内外干眼症患者视力相关生活质量评估工具进行文献检索、整理和分析。结果 干眼症患者视力相关生活质量评估工具主要分为 2 大类别,包括干眼症专用量表和普适性量表。结论 随着视力相关生活质量测评工具的不断开发,干眼症专用测评工具将更有利于全面了解干眼症患者视力相关生活质量的内涵与现况,为护理人员制定个体化干预方案提供临床参考价值。
中图分类号:
- R473.77
| [1] Liyue H, Chiang P C, Sung S C, et al.Dry Eye-Related Visual Blurring and Irritative Symptoms and Their Association with Depression and Anxiety in Eye Clinic Patients[J]. Curr Eye Res, 2016,41(5):590-599.DOI:10.3109/02713683.2015.1056804. [2] Yamada M, Mizuno Y, Shigeyasu C.Impact of Dry Eye on Work Productivity[J]. Clinicoecon Outcomes Res, 2012, 4:307-312. DOI:10.2147/CEOR.S36352. [3] Tilborg M M, Murphy P J, Evans K S.Impact of Dry Eye Symptoms and Daily Activities in a Modern Office[J]. Optom Vis Sci, 2017, 94(6):688.DOI:10.1097/OPX.0000000000001086. [4] Sullivan B D, Crews L A, Messmer E M, et al.Correlations Between Commonly Used Objective Signs and Symptoms for the Diagnosis of Dry Eye Disease: Clinical Implications[J]. Acta Ophthalmol, 2014, 92(2):161-166.DOI:10.1111/aos.12012. [5] Eloy V, María Teresa R A, Dolores A, et al. Prevalence of Asymptomatic and Symptomatic Meibomian Gland Dysfunction in the General Population of Spain[J]. Invest Ophthalmol Vis Sci, 2012, 53(6):2601-2606.DOI:10.1167/iovs.11-9228. [6] Schiffman R M, Christianson M D, Jacobsen G, et al.Reliability and Validity of the Ocular Surface Disease Index[J]. Arch Ophthalmol, 2000, 118(5):615-621. DOI:10.1001/archopht.118.5.615. [7] 林晨,杨敏敏,郑虔.眼表疾病指数量表中文版的研制和性能评价[J]. 眼科新进展, 2013,33(1):38-40.DOI:10.13389/j.cnki.rao.2013.01.011. [8] 马子伟,韩伟,杨卫华. 应用Keratograph眼表综合分析仪分析老年人干眼症状与体征的相关性[J]. 中国老年学杂志, 2019, 39(9):2159-2163. DOI:CNKI:SUN:ZLXZ.0.2019-09-040. [9] Finis D, Pischel N, Schrader S, et al.Evaluation of Lipid Layer Thickness Measurement of the Tear Film as a Diagnostic Tool for Meibomian Gland Dysfunction[J]. Cornea, 2013, 32(12):1549-1553.DOI:10.1097/ICO.0b013e3182a7f3e1. [10] Yazdani M, Chen X, Tashbayev B, et al.Evaluation of the Ocular Surface Disease Index Questionnaire as a Discriminative Test for Clinical Findings in Dry Eye Disease Patients[J].Curr Eye Res, 2019,4(16):972.DOI:10.1080/02713683.2019.1604972. [11] Messina M, Dua H S. Early Results on the Use of Chitosan- N -acetylcysteine (Lacrimera ) in the Management of Dry Eye Disease of Varied Etiology[J]. Int Ophthalmol, 2019,39(3):639-696.DOI10.1007/s10792-018-0843-0. [12] Chen X, Yuan R, Sun M, et al.Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye after Phacoemulsification[J]. BMC Ophthalmology, 2019,19(1):13.DOI:10.1186/s12886-018-1023-8. [13] Abetz L, Rajagopalan K, Mertzanis P, et al.Development and Validation of the Impact of Dry Eye on Everyday Life (IDEEL) Questionnaire, a Patient-Reported Outcomes (PRO) Measure for the Assessment of the Burden of Dry Eye on Patients[J]. Health Qual Life Outcomes, 2011, 9(1):111.DOI:10.1186/1477-7525-9-111. [14] Rajagopalan K, Abetz L, Mertzanis P, et al.Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-related Quality of Life Measures in a Sample of Patients with Dry Eye[J].Value in Health, 2005,8(2):168-174.DOI:10.111/j.1524-4733.2005.03074.x. [15] Acaster S, Verboven Y, Begley C, et al.PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity Groups[J]. Value in Health, 2011,14(7):507-508.DOI:10.1016/j.jval.2011.08.1497. [16] Fairchild C J, Chalmers R L, Begley C G.Clinically Important Difference in Dry Eye: Change in IDEEL-symptom Bother[J]. Optom Vis Sci, 2008,85(8):699-707.DOI:10.1097/OPX.0b013e3181824e0d. [17] Bang Z, Liu X J, Sun Y Q F, et al. Development and Validation of the Chinese Version of Dry Eye Related Quality of Life Scale[J]. Health Qual Life Outcomes, 2017,15(1):145.DOI:10.1186/s12955-017-0718-5. [18] Yuri S, Masahiko Y, Norihiko Y, et al.Development and Validation of the Dry Eye-related Quality-of-life Score Questionnaire[J]. Jama Ophthalmol, 2013,131(10):1331-1338.DOI:10.1001/jamaophthalmol.2013.4503. [19] Yazdani-Ibn-Taz M K, Han M M, Jonuscheit S, et al. Patient-reported Severity of Dry Eye and Quality of Life in Diabetes[J]. Clin ophthalmol, 2019,13:217-224.DOI:10.2147/OPTH.S184173. [20] Kobashi H, Kamiya K, Sambe T, et al.Factors Influencing Subjective Symptoms in Dry Eye Disease[J]. Int J Ophthalmol, 2018, 11(12):1926-1931. DOI:10.18240/ijo.2018.12.08. [21] Ishikawa S, Takeuchi M, Kato N.The Combination of Strip Meniscometry and Dry Eye-related Quality-of-life Score Is Useful for Dry Eye Screening During Health Checkup Cross-Sectional Study[J]. JCR, 2018,97(43):e12969.DOI:10.1097/MD.0000000000012969. [22] Sano K, Kawashima M, Takechi S, et al.Exercise Program Improved Subjective Dry Eye Symptoms for Office Workers[J].Clin Ophthalmol,2018,12:307-311.DOI:10.2147/OPTH.S149986. [23] Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, et al.Creating a Specific Diagnostic and Quality-of-life Questionnaire for Patients with Ocular Surface Disease[J]. J Fr Ophtalmol,2003,26(2):119-130.DOI:10.1167/iovs.02-0361. [24] Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, et al.Severe Impairment of Health-related Quality of Life in Patients Suffering from Ocular Surface Diseases[J]. J Fr Ophtalmol, 2008,31(4):369-378.DOI:10.1016/S0181-5512(08)71431-1. [25] Joseph G, Kyle H, Sue T R, et al.Instrument Development of the UNC Dry Eye Management Scale[J]. Cornea, 2014,33(11):1186-1192.DOI:10.1097/ICO.0000000000000243. [26] Bitar M S, Olson D J, Li M, et al.The Correlation Between Dry Eyes, Anxiety and Depression: The Sicca, Anxiety and Depression Study[J]. Cornea, 2019,38(6):684-689.DOI:10.1097/ICO.0000000000001932. [27] Hwang C J, Ellis R, Davis R M, et al.Determination of the Minimal Clinically Important Difference of the University of North Carolina Dry Eye Management Scale[J]. Cornea, 2017, 36(9):1054-1060. DOI:10.1097/ICO.0000000000001287. [28] Mangione C, Lee P, Pitts J, et al.Psychometric Properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ)[J]. Arch Ophthalmol, 1998, 11(116):1496-1504.DOI:10.1001/archopht.116.11.1496. [29] Mangione C M, Lee P P, Gutierrez P R, et al.Development of the 25-item National Eye Institute Visual Function Questionnaire[J]. Arch Ophthalmol, 2001,119(7):1050.DOI: 10.1097/00132578-200201000-00028. [30] Toprak A, Eser E, Guler C, et al.Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25)[J].Ophthalmic Epidemiol,2005,12(4):11.DOI:10.1080/09286580590967763. [31] Suzukamo Y, Oshika T, Yuzawa M, et al.Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25),Japanese version[J]. Health Qual Life Outcomes,2005,3(1):65.DOI:10.1186/1477-7525-3-65. [32] Labiris G, Katsanos A, Fanariotis M, et al.Psychometric Properties of the Greek Version of the NEI-VFQ 25[J]. BMC Ophthalmol, 2008,8(1):4.DOI:10.1186/1471-2415-8-4. [33] Nordmann J, Sullivan K, Viala M, et al.Psychometric Validation of the NEI-VFQ 25 French Version in a Population of Patients Treated for Ocular Hypertension and Glaucoma[J]. Value in Health, 2003,6(6):641.DOI:10.1016/S1098-3015(10)61642-7. [34] Kovac B, Vukosavljevic M, Kovac J D, et al.Validation and Cross-cultural Adaptation of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in Serbian patients[J]. Health Qual Life Outcomes, 2015,13(1):142.DOI:10.1186/s12955-015-0330-5. [35] Wang C, Chan C L, Jin H.Psychometric Properties of the Chinese Version of the 25-item National Eye Institute Visual Function Questionnaire[J]. Optom Vis Sci, 2008,85(11):1091-1099.DOI:10.1097/OPX.0b013e31818b9f23. [36] Vitale S, Goodman L A, Reed G F, et al.Comparison of the NEI-VFQ and OSDI Questionnaires in Patients With Sjögren's Syndrome-Related Dry Eye[J]. Health Qual Life Outcomes, 2004,2(1):44.DOI:10.1186/1477-7525-2-44. [37] 刘小虎,邹浩东,李娟,等. 中药熏蒸联合泪道栓子对重度干眼患者视觉相关生存质量的影响[J]. 中国中医眼科杂志, 2019, 29(3):202-205.DOI:10.13444/j.cnki.zgzyykzz.2019.03.008. [38] Ji M A, Lee S H, Rim T H T, et al. Prevalence of and Risk Factors Associated with Dry Eye: The Korea National Health and Nutrition Examination Survey 2010-2011[J]. Am J Ophthalmol, 2014,92(4):e317-e325.DOI:10.1111/aos.12355. [39] La P W S, de Souza R B, Gomes J Á, et al. The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease[J]. Am J Ophthalmol, 2016,163:167-173.DOI:10.1016/j.ajo.2015.11.034. |
| [1] | 黄媛媛, 傅巧美, 刘光香, 白雅馨, 张青. 肾移植患者基于“互联网+”延续护理的效果观察[J]. 护理学报, 2020, 27(8): 69-72. |
| [2] | 李寅翠, 刘云, 李莹, 韩雪, 孟嘉. 术前睡眠质量对全膝关节表面置换患者术后早期康复及生活质量的影响[J]. 护理学报, 2020, 27(4): 42-47. |
| [3] | 刘熠, 欧阳艳琼, 黄毅, 聂小菲. 正念减压疗法对乳腺癌患者干预效果的Meta分析[J]. 护理学报, 2019, 26(8): 31-36. |
| [4] | 卞薇, 苏君, 郭文梅, 万君丽, 谭明琼, 王丽华. 医患共同决策测评工具的研究进展[J]. 护理学报, 2019, 26(7): 28-33. |
| [5] | 张鲁敏, 顾芬, 任皎皎, 陈刘莺. 叙事护理对COPD患者焦虑抑郁及生活质量的影响[J]. 护理学报, 2019, 26(7): 65-69. |
| [6] | 杜红娣, 刘彩云, 刘晓萱, 王琳琳, 李莹, 霍晓鹏. 基于蒙台梭利教育理论干预对轻中度老年痴呆患者认知功能及生活质量的影响[J]. 护理学报, 2019, 26(5): 59-62. |
| [7] | 隆莉芝, 袁玲, 严婷婷, 方丽. 头颈癌患者报告结局的研究进展[J]. 护理学报, 2019, 26(21): 26-30. |
| [8] | 朱冰洁, 李佳倩, 黄孟秋, 王蕊, 阎玲. 154例乳腺癌化疗患者症状管理自我效能影响因素分析[J]. 护理学报, 2019, 26(18): 42-46. |
| [9] | 于歌, 崔金金. 二元应对模式对慢性心力衰竭患者生活质量及其配偶间亲密关系的影响[J]. 护理学报, 2019, 26(16): 63-67. |
| [10] | 蔡晓艳, 邓小岚, 张智. 玩偶疗法对阿尔茨海默病患者认知功能和生活质量的影响[J]. 护理学报, 2019, 26(10): 73-76. |
| [11] | 李燕, 单亚维, 张翠娣. 慢性肾脏病中晚期患者体力活动干预方案及评估工具研究进展[J]. 护理学报, 2019, 26(1): 40-44. |
| [12] | 王玲,孙丹,郑莉. 肝移植受者术后小组活动健康教育的效果观察[J]. 护理学报, 2018, 25(6): 64-67. |
| [13] | 黄孟秋,吴婷,张青月,王燕,庞微,阎玲. 症状管理自我效能在乳腺癌患者化疗期间焦虑抑郁与生活质量的中介作用[J]. 护理学报, 2018, 25(4): 65-69. |
| [14] | 王艾红, 张琼, 谢莹莹, 尹安春. 糖尿病患者压力测评工具的研究进展[J]. 护理学报, 2018, 25(23): 22-27. |
| [15] | 罗香莲, 黄雅莲, 方艳春, 宋春莲, 朱婷, 徐俊敏. 团体爱笑瑜伽对维持性血液透析患者生活质量的影响[J]. 护理学报, 2018, 25(22): 1-5. |
|